Bryan J. McMichael - Sep 7, 2022 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Title: Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Bryan J. McMichael
Stock symbol
CHRS
Transactions as of
Sep 7, 2022
Transactions value $
$0
Form type
4
Date filed
9/9/2022, 05:37 PM
Next filing
Jan 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRS Stock Option (Right to Buy) Award $0 +15K $0.00 15K Sep 7, 2022 Common Stock 15K $10.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from September 7, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Remarks:

Title: Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer